Impact of Antibiotic Pretreatment on Bone Biopsy Yield for Children With Acute Hematogenous Osteomyelitis
Acute hematogenous osteomyelitis (AHO) is the most common form of pediatric osteomyelitis. Pathogen-directed therapy is preferable to empirical treatment and appropriate therapy depends on identifi cation of a causative organism; however, blood culture results are positive in only 23% to 60% of cases. [1] [2] [3] [4] [5] [6] The addition of a bone biopsy culture or other tissue culture has been shown to increase the organism detection rate to 45% to 80%. 1, [4] [5] [6] [7] [8] There are limited data on the yield of bone biopsies and the effect of prebiopsy antibiotics on pathogen recovery in osteomyelitis. Several small retrospective studies in adults suggest that there is between a 16% to 56% lower rate of pathogen recovery in fi ne-needle aspirates obtained after the initiation of antibiotics [9] [10] [11] on pathogen recovery in children with AHO is unknown. Some practitioners may withhold antibiotic therapy until after a bone biopsy is obtained because of concerns that antibiotics will reduce the likelihood of a positive culture result, whereas others may be uncomfortable withholding antibiotics. Understanding the impact of pre-bone biopsy antibiotic exposure on pathogen recovery could assist practitioners in making decisions about when to initiate antibiotic therapy in patients with known or suspected AHO. We sought to analyze the association between initiation of antibiotics before bone biopsy and subsequent culture yield.
METHODS
This was a retrospective cohort study of children aged 60 days to 18 years hospitalized at a large children's hospital from 2011 to 2012 with a diagnosis of AHO (versus contiguous osteomyelitis) who underwent a bone biopsy. Patients were identifi ed from 3 sources: hospital discharge diagnoses (International Classifi cation of Diseases, Ninth Revision codes 730, 730.2, 730.3, 730.8, and 730.9), records of the infectious disease service, and microbiology laboratory. A diagnosis of AHO was established based on compatible signs and symptoms of disease confi rmed by MRI changes consistent with osteomyelitis (defi ned as bone marrow signal intensity alterations consistent with infl ammation with or without associated marrow necrosis, suppuration, periosteal reaction, or cortical bone destruction), 13 and histopathologic specimens consistent with osteomyelitis (defi ned as positive blood or bone culture or histologic changes on bone biopsy consistent with osteomyelitis). Patients were excluded if they were immunocompromised (asplenia, HIV, malignancy, primary immune disorders, chronic immunosuppressive therapy, or sickle cell disease), had received antibiotic therapy for >1 week's duration at the time of presentation, had chronic osteomyelitis (defi ned as symptoms compatible with osteomyelitis present for >2 weeks and radiographic evidence of devitalized bone or pathology consistent with chronic osteomyelitis), had penetrating trauma or postoperative infections, had cultures obtained only from subperiosteal fl uid collections or abscesses, or were transferred from a referring hospital with incomplete documentation of antibiotic or laboratory data. Records were reviewed to identify patient demographics, clinical symptoms, physical examination, and laboratory, microbiologic, pathology, and radiographic fi ndings. Records also were abstracted for the timing and selection of antibiotics. The study was approved by the local institutional review board. Frequencies were calculated for descriptive variables. Continuous variables were analyzed with t tests or Wilcoxon rank sum.
Dichotomous variables were analyzed with χ 2 or Fisher's exact test. Stata 11 (Stata, Inc., College Station, TX) was used for analyses.
RESULTS
A total of 181 patients were diagnosed with AHO ( Figure) and 112 met inclusion criteria, of whom 67 (60%) received bone biopsy. Thirty-seven biopsies (55%) were operative and 30 (45%) were performed by interventional radiology; the culture yields were 86% and 43%, respectively (odds ratio [OR] 8.4, 95% confi dence interval [CI] 2.6-27.4). The demographics of the study population are described in Table 1 and compared with children not receiving bone biopsy. The clinical and laboratory fi ndings are described in Table 2 . Of the children receiving bone biopsies, only 2 (3%) were described as toxic-appearing. Children who received antibiotics did not differ in physical examination fi ndings, but were more likely to have a higher peripheral white blood cell count and C-reactive protein, as well as being more likely to have a joint effusion visualized on MRI ( Table 2) . The most common antibiotics used before biopsy were vancomycin (19/40, 48%) and clindamycin (17/40, 43%). This refl ected local antibiotic resistance patterns. The local rates of MRSA were high (>60%) among all skin/ soft tissue infections, and rates of clindamycin resistance increased to 20% during the study period. Fourteen children (21%) had complications, with the most common being a need for repeat operative intervention (6), new abscess formation (3), multifocal osteomyelitis (2), and pathologic fracture (2) . Twelve had received antibiotics before biopsy.
DISCUSSION
This study demonstrated several interesting associations. First, antibiotic pretreatment was not associated with a decrease in bone biopsy culture yield when antibiotic use was treated as a dichotomous outcome. However, longer antibiotic durations before biopsy were associated with reduced culture yield. Importantly, for many children in our study, the only microbiologic diagnosis was derived from a bone biopsy.
Bone biopsy yield did not appear to be associated with antibiotic pretreatment in this pediatric cohort. This may be because of differences in illness severity. Children who were pretreated with antibiotics were more likely to be bacteremic, and had higher white blood cell counts and infl ammatory markers than children who were not pretreated. As this was a retrospective cohort study, children were not randomized to a given intervention. A higher proportion of bacteremic children receiving antibiotics likely refl ects clinical recognition of increased disease severity. Despite pretreatment, these children www.hospitalpediatrics.org may have had positive bone biopsy cultures because of their bacterial load. In many instances, a bacteremic child underwent an intervention by surgery or interventional radiology not because a bone biopsy was pursued for a microbiologic diagnosis, but rather because the child had a purulent fl uid collection that needed to be drained. In other instances, the antibiotics received (eg, ceftriaxone or amoxicillin/clavulanate) in the outpatient setting would not have provided coverage for the most common organisms causing AHO.
Although antibiotic receipt before biopsy was not associated with culture results when considered as a dichotomous variable, the duration of antibiotic use before biopsy was associated with culture yield. This is an important consideration when clinicians are faced with the dilemma of withholding antibiotics pending a biopsy. A child admitted over a weekend may not receive a biopsy until the next weekday when procedural sedation may be more feasible. Although clinicians may feel comfortable withholding antibiotics for a short period pending biopsy, others may question the justifi cation behind hospitalizing a child with a suspected bone infection for observation off of antibiotics.
For one-third of the patients, the etiology of AHO was determined only via bone biopsy. This is concordant with previously published literature. [1] [2] [3] [4] [5] [6] [7] [8] This may be because it takes longer to sterilize bone than blood. In an era of increasing antibiotic resistance, isolation of a pathogen becomes critical to targeting not only initial parenteral antibiotics, but also assisting with the decision to transition from intravenous to oral therapy. Some infectious disease clinicians may feel more comfortable transitioning a child to oral therapy if an etiology and antibiotic susceptibilities are available.
There were limitations to this study. Given the retrospective nature, not all variables were documented for all patients and this was particularly true for elements of the history and physical examination. We excluded children who had received antibiotics for more than 1 week to exclude children who received antibiotics for other presumed etiologies (eg, acute otitis media) before recognition of the full spectrum of AHO. There was a selection bias in which children received antibiotics before biopsy, which antibiotics were administered, and likely illness severity; all of these are possible factors that could have accounted for the results. Indications for bone biopsy were not always evident from the medical record. The hospital implemented a new clinical pathway for AHO in 2011 that strongly recommended bone biopsy and led to increased cases during the last year of the study period. The sample size was relatively small, and a multicenter study would add substantially to the existing data.
In conclusion, although bone biopsy results were not affected by antibiotic receipt, a longer duration of antibiotic therapy before bone biopsy was associated with lower culture yield. In one-third of children, only the bone biopsy culture produced a microbiological diagnosis. Clinicians should coordinate with subspecialists to obtain early bone biopsy in children with suspected osteomyelitis.
